| Target Price | A$5.20 |
| Price | A$4.90 |
| Potential |
6.16%
register free of charge
|
| Number of Estimates | 11 |
|
11 Analysts have issued a price target Medibank Private 2026 .
The average Medibank Private target price is A$5.20.
This is
6.16%
register free of charge
A$5.99
22.14%
register free of charge
A$4.70
4.15%
register free of charge
|
|
| A rating was issued by 14 analysts: 5 Analysts recommend Medibank Private to buy, 8 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Medibank Private stock has an average upside potential 2026 of
6.16%
register free of charge
|
| Jun '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion A$ | 8.16 | 9.19 |
| 4.61% | 12.71% | |
| EBITDA Margin | 10.14% | 9.20% |
| 1.52% | 9.27% | |
| Net Margin | 6.14% | 7.09% |
| 2.79% | 15.46% |
7 Analysts have issued a sales forecast Medibank Private 2026 . The average Medibank Private sales estimate is
This results in the following potential growth metrics:
5 Analysts have issued an Medibank Private EBITDA forecast 2026. The average Medibank Private EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
12 Medibank Private Analysts have issued a net profit forecast 2026. The average Medibank Private net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Jun '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share A$ | 0.18 | 0.24 |
| 0.00% | 33.33% | |
| P/E | 20.45 | |
| EV/Sales | 1.41 |
12 Analysts have issued a Medibank Private forecast for earnings per share. The average Medibank Private EPS is
This results in the following potential growth metrics and future valuations:
Medibank Private...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| JEFFERIES |
Locked
➜
Locked
|
Locked | Sep 08 2025 |
| MACQUARIE RESEARCH |
Locked
➜
Locked
|
Locked | Sep 01 2025 |
| JEFFERIES |
Locked
➜
Locked
|
Locked | Jul 17 2025 |
| JEFFERIES |
Locked
➜
Locked
|
Locked | Jul 16 2025 |
| MACQUARIE RESEARCH |
Locked
➜
Locked
|
Locked | Jul 14 2025 |
| MACQUARIE RESEARCH |
Locked
➜
Locked
|
Locked | Jul 13 2025 |
| MACQUARIE RESEARCH |
Locked
➜
Locked
|
Locked | Mar 18 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Sep 08 2025 |
|
Locked
MACQUARIE RESEARCH:
Locked
➜
Locked
|
Sep 01 2025 |
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Jul 17 2025 |
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Jul 16 2025 |
|
Locked
MACQUARIE RESEARCH:
Locked
➜
Locked
|
Jul 14 2025 |
|
Locked
MACQUARIE RESEARCH:
Locked
➜
Locked
|
Jul 13 2025 |
|
Locked
MACQUARIE RESEARCH:
Locked
➜
Locked
|
Mar 18 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


